• 首页期刊简介编委会刊物订阅专栏专刊电子刊学术动态联系我们English
引用本文:丛海涛,王惠琴,范正芬,陈斌.不同剂量右美托咪定滴鼻在麻醉诱导前的应用比较[J].中国现代应用药学,2015,32(7):882-886.
CONG Haitao,WANG Huiqin,FAN Zhengfen,CHEN Bin.Comparison of Different Doses of Intranasal Dexmedetomidine Application Before General Anesthesia Induction[J].Chin J Mod Appl Pharm(中国现代应用药学),2015,32(7):882-886.
【打印本页】   【HTML】   【下载PDF全文】   查看/发表评论  【EndNote】   【RefMan】   【BibTex】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 2495次   下载 1925 本文二维码信息
码上扫一扫!
分享到: 微信 更多
不同剂量右美托咪定滴鼻在麻醉诱导前的应用比较
丛海涛1, 王惠琴1, 范正芬2, 陈斌1
1.浙江省台州医院麻醉科,浙江 临海 317000;2.浙江省台州医院放射科,浙江 临海 317000
摘要:
目的 探讨右美托咪定(dexmedetomidine,DEX)滴鼻在麻醉诱导前应用的最佳剂量。方法 择期手术的120例患者随机分为对照组和DEX 0.5,1.5,2.5 μg·kg-1组,术前30 min分别滴鼻生理盐水和相应剂量DEX。观察DEX滴鼻后30 min镇静评分、插管后血流动力学变化(平均动脉压和心率)和不良事件发生例数、拔管时间、拔管后镇痛评分、拔管后发生躁动情况。结果 DEX各剂量滴鼻后患者30 min OAA/S评分均下降(P<0.05);DEX 1.5 μg·kg-1组滴鼻后30 min HR和MAP下降(P<0.05);插管即刻,对照组、DEX 0.5 μg·kg-1组HR和MAP上升,DEX 2.5 μg·kg-1组HR和MAP下降(P<0.05);DEX 1.5 μg·kg-1组及DEX 2.5 μg·kg-1组心动过速、高血压发生例数减少(P<0.05);DEX 2.5 μg·kg-1组心动过缓、低血压发生例数增多(P<0.05),拔管时间延长(P<0.05);DEX 1.5和2.5 μg·kg-1组拔管后镇痛VAS评分、发生躁动例数下降(P<0.05)。结论 麻醉诱导前30 min经鼻滴入DEX 1.5 μg·kg-1可以平稳完成气管插管,同时减少各种不良反应。
关键词:  右美托咪定  滴鼻  麻醉诱导  气管插管  血流动力学
DOI:
分类号:
基金项目:
Comparison of Different Doses of Intranasal Dexmedetomidine Application Before General Anesthesia Induction
CONG Haitao1, WANG Huiqin1, FAN Zhengfen2, CHEN Bin1
1.Department of Anesthesia, Taizhou Hospital, Linhai 317000, China;2.Department of Radiology, Taizhou Hospital, Linhai 317000, China
Abstract:
OBJECTIVE To investigate the right dose of intranasal dexmedetomidine(DEX) application before anesthesia induction. METHODS All of 120 cases received surgery were randomly divided into four groups, including intranasal 0.9% sodium chloride, 0.5, 1.5, 2.5 μg·kg-1 DEX groups. Endotracheal intubation and mechanical ventilation were done after anesthesia induction. The patients were sent to the recovery room after operation. Monitoring indicators including intranasal DEX sedation score 30 min later, hemodynamic changes after intubation (mean arterial pressure and heart rate) and the incidence of adverse events, extubation time, pain score and cases of agitation. RESULTS OAA/S score in DEX 0.5, 1.5 and 2.5 μg·kg-1 group decreased 30 min after intranasal(P<0.05); HR and MAP in DEX 1.5 μg·kg-1 group decreased 30 min after intranasal(P<0.05); HR and MAP in the control group and DEX 0.5 μg·kg-1 group increased at immediate intubation, while decreased in DEX 2.5 μg·kg-1 group(P<0.05). The cases of tachycardia and hypertension in DEX 1.5 μg·kg-1 group and DEX 2.5 μg·kg-1 group decreased(P<0.05). The cases of bradycardia and hypotension increased increased in DEX 2.5 μg·kg-1 group(P<0.05). Extubation time in DEX 2.5 μg·kg-1 group was extended(P<0.05). The VAS score after extubation and the cases of agitation in DEX 1.5 and 2.5 μg·kg-1 group were decreased(P<0.05). CONCLUSION Endotracheal intubation can be well done with intranasal DEX 1.5 μg·kg-1 30 min before anesthesia induction, at the same time all kinds of adverse reactions were reduced.
Key words:  dexmedetomidine  intranasal  anesthesia induction  tracheal intubation  hemodynamics
扫一扫关注本刊微信